Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Awakening Spleen Capsule (Xingpi Jiaonang) is a Traditional Chinese Medicine (TCM) formulation indicated for the treatment of functional gastrointestinal disorders (FGID) and irritable bowel syndrome (IBS). It is primarily used to address symptoms associated with spleen deficiency and dampness, such as abdominal pain, bloating, and diarrhea. The capsule contains a blend of herbal extracts that work synergistically to regulate gastrointestinal motility and modulate the secretion of gut hormones like motilin and gastrin. It has been the subject of real-world clinical application surveys conducted by the China Academy of Chinese Medicine Sciences to further define its dosing and efficacy in adult populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Awakening Spleen Capsule.